Provided by Tiger Trade Technology Pte. Ltd.

RenovoRx Inc

1.42
+0.170013.60%
Pre-market: 1.550.1268+8.93%05:44 EDT
Volume:1.35M
Turnover:1.95M
Market Cap:63.97M
PE:-4.59
High:1.56
Open:1.30
Low:1.27
Close:1.25
52wk High:1.56
52wk Low:0.7006
Shares:45.05M
Float Shares:39.17M
Volume Ratio:3.43
T/O Rate:3.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3096
EPS(LYR):-0.3161
ROE:-125.23%
ROA:-64.90%
PB:7.12
PE(LYR):-4.49

Loading ...

RenovoRx Inc - Appoints Ramtin Agah as Executive Chairman Effective February 27, 2026 - SEC Filing

THOMSON REUTERS
·
Mar 27

RenovoRx appoints Ramtin Agah executive chairman; base salary rises to $450,000

Reuters
·
Mar 27

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 27

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 25

RenovoRx director Laurence Marton acquires USD 10,000 of common shares

Reuters
·
Mar 25

RenovoRx CEO Shaun Bagai reports USD 25,000 acquisition of common shares

Reuters
·
Mar 25

RenovoRx CFO Mark Voll files initial beneficial ownership statement

Reuters
·
Mar 25

RenovoRx Announces Closing of Oversubscribed $10 Million at Market Private Placement

GlobeNewswire
·
Mar 23

RenovoRx Raises $10 Million in Oversubscribed Private Placement

TIPRANKS
·
Mar 23

RenovoRx to host Q4 and full-year 2025 financial results conference call

Reuters
·
Mar 20

BUZZ-U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies

Reuters
·
Mar 19

BUZZ-U.S. STOCKS ON THE MOVE-Tencent, Air Products, Protagonist

Reuters
·
Mar 18

BUZZ-RenovoRx rises after $10 mln private stock sale to fund cancer trial, device rollout

Reuters
·
Mar 18

BRIEF-Renovorx Announces $10 Million At Market Private Placement

Reuters
·
Mar 18

RenovoRx announces USD 10 million private placement of common stock and warrants

Reuters
·
Mar 18

RenovoRx Inc - to Issue 10.6 Mln Shares at $0.938 per Share With 50% Warrant Coverage

THOMSON REUTERS
·
Mar 18

RenovoRx Names Ramtin Agah Executive Chairman

Reuters
·
Feb 27

RenovoRx Advancing RenovoCath® Adoption at U.S. Cancer Centers, Strengthening Clinical and Commercial Momentum

GlobeNewswire
·
Feb 27